STRO — Sutro Biopharma Share News
0.000.00%
Last trade - 00:00- $154.70m
- $229.42m
- $102.48m
Sutro Biopharma gains as Oppenheimer initiates coverage with 'outperform'
Sutro Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sutro Biopharma Q2 Revenue USD 10.412 Million Vs. IBES Estimate USD 12.6 Million
Sutro Biopharma Inc expected to post a loss of 73 cents a share - Earnings Preview
Brief: Sutro Biopharma And Blackstone Announce Royalty Financing Collaboration
Brief: Sutro Biopharma Gets Notice Of Termination From Celgene Of Amended, Restated Collaboration, License Agreement
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
Brief: Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights And Select Anticipated Milestones
Brief: Sutro Biopharma posts Q1 basic EPS USD -0.85
Brief: Sutro Biopharma Announces The Departure Of President Of Research & Chief Scientific Officer
Brief: Sutro Biopharma Presents Preclinical Data For Its Ror1 Targeting Antibody Drug Conjugate Stro-003 At Aacr Annual Meeting 2023
U.S. RESEARCH ROUNDUP-Apple, Intel, Tesla
Sutro Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights And Select Anticipated Milestones
Sutro Biopharma Inc expected to post a loss of 62 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Sutro Biopharma, NI, Estee Lauder
Sutro Biopharma gains; Truist raises PT on co
Brief: Sutro Biopharma Announces Update From Stro-002, Luveltamab Tazevibulin, Phase 1 Dose-Expansion Study
U.S. STOCKS ON THE MOVE-Nike, Venus Concept, Zymeworks